Skip to main content

Advertisement

SpringerLink
Log in

Hypoventilation Syndromes

  • Sleeping and Breathing (T Lee-Chiong)
  • Published:
Current Pulmonology Reports Aims and scope Submit manuscript

Abstract

Purpose of Review

This chapter provides a concise yet comprehensive overview of hypoventilation syndromes for the medical provider and offers a brief overview of the latest developments in treatments of the conditions listed.

Recent Findings

There have been few advances in the field of genetics to develop medications that target the function of genes responsible for congenital diseases that cause hypoventilation. Despite these few advances, larger-scale interventional studies need to be done. Diaphragmatic pacing and positive airway pressure (PAP) modalities continue to be used for treatment of certain hypoventilation syndromes.

Summary

The best and most widely tested and efficient treatments for hypoventilation remain positive airway pressure therapy. Although there are treatment advances, they should continue to be utilized in conjunction with PAP therapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Fishman LS. Primary alveolar hypoventilation syndrome (Ondine’s curse). Am J Dis Child. 1965;110:155–61. doi:10.1001/archpedi.1965.02090030165011.

    Article  CAS  PubMed  Google Scholar 

  2. Chin TW, Chen JJ, Maharaj S. Congenital central hypoventilation syndrome. Congenital central hypoventilation syndrome: background, pathophysiology, epidemiology. In: http://emedicine.medscape.com/article/1002927-overview. (2014). Accessed Jan 28th 2017.

  3. Boing S, Randerath W. Chronic hypoventilation syndromes and sleep-related hypoventilation. Journal of Thoracic Disease. 2015;7:1273–85. doi:10.3978/j.issn.2072-1439.2015.06.10.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Preutthipan A, Kuptanon T, Kamalaporn H, Leejakpai A, Nugboon M, Wattanasirichaigoon D. Using non-invasive bi-level positive airway pressure ventilator via tracheostomy in children with congenital central hypoventilation syndrome: two case reports. J Med Case Rep. 2015; doi:10.1186/s13256-015-0631-7.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Cielo CM, Marcus CL. Central hypoventilation syndromes. Sleep Medicine Clinics. 2014;9:105–18. doi:10.1016/j.jsmc.2013.10.005.

    Article  PubMed  Google Scholar 

  6. Nicholson KJ, Nosanov LB, Bowen KA, Kun SS, Perez IA, Keens TG, Shin CE. Thoracoscopic placement of phrenic nerve pacers for diaphragm pacing in congenital central hypoventilation syndrome. J Pediatr Surg. 2015;50:78–81. doi:10.1016/j.jpedsurg.2014.10.002.

    Article  PubMed  Google Scholar 

  7. Straus C, Trang H, Becquemin M-H, Touraine P, Similowski T. Chemosensitivity recovery in Ondine’s curse syndrome under treatment with desogestrel. Respir Physiol Neurobiol. 2010;171:171–4. doi:10.1016/j.resp.2010.03.015.

    Article  CAS  PubMed  Google Scholar 

  8. •• Joubert F, Perrin-Terrin A-S, Verkaeren E, Cardot P, Fiamma M-N, Frugière A, Rivals I, Similowski T, Straus C, Bodineau L. Desogestrel enhances ventilation in ondine patients: animal data involving serotoninergic systems. Neuropharmacology. 2016;107:339–50. doi:10.1016/j.neuropharm.2016.03.041. Desogestrel enhances ventilation in Ondine patients: animal data involving serotoninergic systems. This highlights newer medical treatments for hypoventilation which may be a possible alternative to PAP therapy or may be used in conjunction with PAP therapy for added benefit

    Article  CAS  PubMed  Google Scholar 

  9. •• Zanni ED, Bachetti T, Parodi S, Bocca P, Prigione I, Lascio SD, Fornasari D, Ravazzolo R, Ceccherini I. In vitro drug treatments reduce the deleterious effects of aggregates containing polyAla expanded PHOX2B proteins. Neurobiol Dis. 2012;45:508–18. doi:10.1016/j.nbd.2011.09.007. In vitro drug treatments reduce the deleterious effects of aggregates containing polyAla expanded PHOX2B proteins. I highlighted this despite being an older study as it represents a possible cure for the disease using targeted therapy. It is unclear as to how long the effect of treatment lasts and the effect on hypoventilation in human subjects. Further testing would be prudent.

    Article  CAS  PubMed  Google Scholar 

  10. Praud J-P. Central hypoventilation syndrome. Paediatr Respir Rev. 2010; doi:10.1016/s1526-0542(10)70069-5.

    Article  PubMed  Google Scholar 

  11. Rapid-onset obesity with hypothalamic dysfunction, hypoventilation, and autonomic dysregulation. In: NORD (National Organization for Rare Disorders). https://rarediseases.org/rare-diseases/rapid-onset-obesity-with-hypothalamic-dysfunction-hypoventilation-and-autonomic-dysregulation/. Accessed 28 Jan 2017.

  12. Ize-Ludlow D, Gray JA, Sperling MA, Berry-Kravis EM, Milunsky JM, Farooqi IS, Rand CM, Weese-Mayer DE. Rapid-onset obesity with hypothalamic dysfunction, hypoventilation, and autonomic dysregulation presenting in childhood. Pediatrics. 2007;120 doi:10.1542/peds.2006-3324.

    Article  Google Scholar 

  13. Reppucci D, Hamilton J, Yeh EA, Katz S, Al-Saleh S, Narang I. ROHHAD syndrome and evolution of sleep disordered breathing. Orphanet Journal of Rare Diseases. 2016;11:106. doi:10.1186/s13023-016-0484-1.

    Article  PubMed  PubMed Central  Google Scholar 

  14. • Jacobson LA, Rane S, Mcreynolds LJ, Steppan DA, Chen AR, Paz-Priel I. Improved behavior and neuropsychological function in children with ROHHAD after high-dose cyclophosphamide. Pediatrics. 2016;138 doi:10.1542/peds.2015-1080. Improved behavior and neuropsychological function in children with ROHHAD after high-dose cyclophosphamide. Further studies on the effects of this treatment on hypoventilation would be interesting. Possible alternative therapy and long-term side effects should also be documented. Current studies are underway with results pending.

    Article  Google Scholar 

  15. Evrensel A, Erensoy H, Ceylan M. Psychiatric symptoms in rapid-onset obesity with hypothalamic dysfunction, hypoventilation, and autonomic dysregulation syndrome and its treatment: a case report. Chin Med J. 2016;129:242–3. doi:10.4103/0366-6999.173550.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Scheimann A. Prader-Willi syndrome. In: Prader-Willi syndrome: background, pathophysiology, epidemiology. (2015) http://emedicine.medscape.com/article/947954-followup. Accessed 28 Jan 2017.

  17. Yee BJ, Buchanan PR, Mahadev S, Banerjee D, Liu PY, Phillips C, Loughnan G, Steinbeck K, Grunstein RR. Assessment of sleep and breathing in adults with Prader-Willi syndrome: a case control series. J Clin Sleep Med. 2007;3:713–8.

    Article  Google Scholar 

  18. Pavone M, Caldarelli V, Khirani S, et al. Sleep disordered breathing in patients with Prader-Willi syndrome: a multicenter study. Pediatr Pulmonol. 2015;50:1354–9. doi:10.1002/ppul.23177.

    Article  PubMed  Google Scholar 

  19. Grugni G, Sartorio A, Crinò A. Growth hormone therapy for Prader–Willi syndrome: challenges and solutions. Ther Clin Risk Manag. 2016;12:873–81. doi:10.2147/TCRM.S70068.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Al-Saleh S, Al-Naimi A, Hamilton J, Zweerink A, Iaboni A, Narang I. Longitudinal evaluation of sleep-disordered breathing in children with Prader-Willi syndrome during 2 years of growth hormone therapy. J Pediatr. 2013;162:263–8. doi:10.1016/j.jpeds.2012.07.042.

    Article  PubMed  Google Scholar 

  21. Knani I, Earley BJ, Udi S, et al. Targeting the endocannabinoid/CB1 receptor system for treating obesity in Prader–Willi syndrome. Molecular Metabolism. 2016;5:1187–99. doi:10.1016/j.molmet.2016.10.004.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. •• Kim Y, Lee H-M, Xiong Y, Sciaky N, Hulbert SW, Cao X, Everitt JI, Jin J, Roth BL, Jiang Y-H. Targeting the histone methyltransferase G9a activates imprinted genes and improves survival of a mouse model of Prader–Willi syndrome. Nat Med. 2016; doi:10.1038/nm.4257. Targeting the histone methyltransferase G9a activates imprinted genes and improves survival of a mouse model of Prader–Willi syndrome. Targeted gene therapy which in the future can be applied to human cases with potential cure of the disease. Further studies in human subjects are necessary

    Article  PubMed  PubMed Central  Google Scholar 

  23. Vaphiades MS, Braswell R. Resolution of Chiari I malformation following acetazolamide therapy. Semin Ophthalmol. 2007;22:9–11. doi:10.1080/08820530601162966.

    Article  PubMed  Google Scholar 

  24. Milerad J, Lagercrantz H, Johnson P. Obstructive sleep apnea in Arnold-Chiari malformation treated with acetazolamide. Acta Paediatr. 1992;81:609–12. doi:10.1111/j.1651-2227.1992.tb12311.x.

    Article  CAS  PubMed  Google Scholar 

  25. Frampton JE. Oxycodone/naloxone PR: a review in severe refractory restless legs syndrome. CNS Drugs. 2015;29:511–8. doi:10.1007/s40263-015-0254-y.

    Article  CAS  PubMed  Google Scholar 

  26. Aurora RN, Kristo DA, Bista SR, Rowley JA, Zak RS, Casey KR, Lamm CI, Tracy SL, Rosenberg RS. The treatment of restless legs syndrome and periodic limb movement disorder in adults—an update for 2012: practice parameters with an evidence-based systematic review and meta-analyses. Focus. 2014;12:99–121. doi:10.5665/sleep.1988.

    Article  Google Scholar 

  27. Lydic R, Keifer JC, Baghdoyan HA, Craft R, Angel C. Opiate action on sleep and breathing. Principles and practice of sleep medicine sixth edition (2017).

    Google Scholar 

  28. • Cao M, Cardell C-Y, Willes L, Mendoza J, Benjafield A, Kushida C. A novel adaptive servoventilation (ASVAuto) for the treatment of central sleep apnea associated with chronic use of opioids. J Clin Sleep Med. 2014;10:855–61. doi:10.5664/jcsm.3954. Adaptive servoventilation (ASVAuto) for the treatment of central sleep apnea associated with chronic use of opioids. Provides an important update to current best practices.

    Article  PubMed  PubMed Central  Google Scholar 

  29. National Institutes of Health. In: National Institutes of Health. https://www.ninds.nih.gov/Disorders/All-Disorders/Leighs-Disease-Information-Page. Accessed 28 Jan 2017

  30. Lee HF, Tsai CR, Chi CS, Lee HJ, Chen CC. Leigh syndrome: clinical and neuroimaging follow up. Pediatr Neurol. 2009;40:88–93. doi:10.1016/j.pediatrneurol.2008.09.020.

    Article  PubMed  Google Scholar 

  31. Fujii T, Ito M, Miyajima T, Okuno T. Dichloroacetate therapy in Leigh syndrome with a mitochondrial T8993C mutation. Pediatr Neurol. 2002;27:58–61. doi:10.1016/S0887-8994(02)00378-8.

    Article  PubMed  Google Scholar 

  32. Koga Y, Povalko N, Katayama K, Kakimoto N, Matsuishi T, Naito E, Tanaka M. Beneficial effect of pyruvate therapy on Leigh syndrome due to a novel mutation in PDH E1α gene. Brain Dev. 2012;34:87–91. doi:10.1016/j.braindev.2011.03.003.

    Article  PubMed  Google Scholar 

  33. Hilz MJ, Moeller S, Buechner S, Czarkowska H, Ayappa I, Axelrod FB, Rapoport DM. Obstructive sleep-disordered breathing is more common than central in mild familial dysautonomia. J Clin Sleep Med. 2016;12:1607–14. doi:10.5664/jcsm.6342.

    Article  PubMed  PubMed Central  Google Scholar 

  34. Sturm R, Hattori A. Morbid obesity rates continue to rise rapidly in the United States. Int J Obes. 2012;37:889–91. doi:10.1038/ijo.2012.159.

    Article  Google Scholar 

  35. Mokhlesi B. Obesity-hypoventilation syndrome. In: Principles and practice of sleep medicine, 6th ed. Elsevier, pp 1189–1199 (2017).

  36. Al Dabal L, BaHammam AS. Obesity hypoventilation syndrome. Annals of Thoracic Medicine. 2009;4:41–9. doi:10.4103/1817-1737.49411.

    Article  PubMed  PubMed Central  Google Scholar 

  37. •• Howard ME, Piper AJ, Stevens B, et al. A randomised controlled trial of CPAP versus non-invasive ventilation for initial treatment of obesity hypoventilation syndrome. Thorax. 2016; doi:10.1136/thoraxjnl-2016-208559. A randomised controlled trial of CPAP versus non-invasive ventilation for initial treatment of obesity hypoventilation syndrome. This study provides an important update to current best practices as well as providing a guide to best treatment option.

    Article  PubMed  Google Scholar 

  38. Shah AK, Goldberg WD. Myasthenia gravis. In: Myasthenia gravis: practice essentials, background, anatomy. (2016) http://emedicine.medscape.com/article/1171206-overview. Accessed 28 Jan 2017.

  39. Longo DL. Harrison’s principles of internal medicine, 18th ed. McGraw-Hill, New York. Chapters 387–388 Pages 3487–3517 (2012).

  40. Lai Y-C, Chen J-Y, Wu H-D, Yang C-C, Lin C-H, Lee P-L. Sleep disordered breathing mimicking myasthenia crisis in a patient with myasthenia gravis. J Clin Sleep Med. 2016;12:767–9. doi:10.5664/jcsm.5816.

    Article  PubMed  PubMed Central  Google Scholar 

  41. Lizarraga K, Benatar M, Lizarraga A. Getting rid of weakness in the ICU: an updated approach to the acute management of myasthenia gravis and Guillain-Barré syndrome. Semin Neurol. 2016;36:615–24. doi:10.1055/s-0036-1592106.

    Article  PubMed  Google Scholar 

  42. Rabinstein AA. Noninvasive ventilation for neuromuscular respiratory failure. Curr Opin Crit Care. 2016;22:94–9. doi:10.1097/MCC.0000000000000284.

    Article  PubMed  Google Scholar 

  43. Adıgüzel N, Karakurt Z, Güngör G, Moçin Ö, Balcı M, Saltürk C, Kargın F, Takır HB, Güven A, Yarkın T. Management of kyphoscoliosis patients with respiratory failure in the intensive care unit and during long term follow up. Multidisciplinary Respiratory Medicine. 2012;7:30. doi:10.1186/2049-6958-7-30.

    Article  PubMed  PubMed Central  Google Scholar 

  44. Nicolini A, Barlascini C, Piroddi I, Garuti G, Banfi P. Effectiveness and safety of mouthpiece ventilation and nocturnal non-invasive ventilation in patients with kyphoscoliosis: short and long-term outcomes after an episode of acute respiratory failure. Revista Portuguesa de Pneumologia (English Edition). 2016;22:75–81. doi:10.1016/j.rppnen.2015.09.009.

    Article  CAS  Google Scholar 

  45. Marin JOM, Carizzo SJ. Overlap syndromes of sleep and breathing disorders. In: Principles and practices of sleep medicine. 6th ed. Elsevier, pp 1179–1188. (2017).

  46. Altintas N. Update: non-invasive positive pressure ventilation in chronic respiratory failure due to COPD. COPD: J Chron Obstruct Pulmon Dis. 2015;13:110–21. doi:10.3109/15412555.2015.1043520.

    Article  Google Scholar 

  47. Sharma B, Neilan TG, Kwong RY, Mandry D, Owens RL, Mcsharry D, Bakker JP, Malhotra A. Evaluation of right ventricular remodeling using cardiac magnetic resonance imaging in co-existent chronic obstructive pulmonary disease and obstructive sleep apnea. COPD: J Chron Obstruct Pulmon Dis. 2012;10:4–10. doi:10.3109/15412555.2012.719050.

    Article  Google Scholar 

  48. Machado M-CL, Vollmer WM, Togeiro SM, Bilderback AL, Oliveira M-VC, Leitao FS, Queiroga F, Lorenzi-Filho G, Krishnan JA. CPAP and survival in moderate-to-severe obstructive sleep apnoea syndrome and hypoxaemic COPD. Eur Respir J. 2009;35:132–7. doi:10.1183/09031936.00192008.

    Article  PubMed  Google Scholar 

  49. Lancaster LH, Mason WR, Parnell JA, Rice TW, Loyd JE, Milstone AP, Collard HR, Malow BA. Obstructive sleep apnea is common in idiopathic pulmonary fibrosis. Chest. 2009;136:772–8. doi:10.1378/chest.08-2776.

    Article  PubMed  PubMed Central  Google Scholar 

  50. Milioli G, Bosi M, Poletti V, Tomassetti S, Grassi A, Riccardi S, Terzano MG, Parrino L. Sleep and respiratory sleep disorders in idiopathic pulmonary fibrosis. Sleep Med Rev. 2016;26:57–63. doi:10.1016/j.smrv.2015.03.005.

    Article  PubMed  Google Scholar 

  51. Serrano-Pariente J, Plaza V, Soriano JB, Mayos M, Lopez-Vina A, Picado C, Vigil L. Asthma outcomes improve with continuous positive airway pressure for obstructive sleep apnea. Allergy. 2016; doi:10.1111/all.13070.

    Article  PubMed  PubMed Central  Google Scholar 

  52. •• Kauppi P, Bachour P, Maasilta P, Bachour A. Long-term CPAP treatment improves asthma control in patients with asthma and obstructive sleep apnoea. Sleep and Breathing. 2016;20:1217–24. doi:10.1007/s11325-016-1340-1. Long-term CPAP treatment improves asthma control in patients with asthma and obstructive sleep apnoea. This study highlights the effect of sleep apnea on the other disease processes that might have been overlooked otherwise.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. School of Medicine, University of Colorado Denver, Denver, USA

    Sheila C. Tsai

  2. Section of Sleep Medicine, National Jewish Health, Denver, USA

    April Shepherd & Sheila C. Tsai

Authors
  1. April Shepherd
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sheila C. Tsai
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to April Shepherd.

Ethics declarations

Conflict of Interest

April Shepherd declares no conflict of interest.

Sheila Tsai reports grants from Resmed.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

This article is part of the Topical Collection on Sleeping and Breathing

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Shepherd, A., Tsai, S.C. Hypoventilation Syndromes. Curr Pulmonol Rep 6, 82–89 (2017). https://doi.org/10.1007/s13665-017-0178-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13665-017-0178-8

Keywords

Search

Navigation